GNA Biosolutions


Contact Stephanie Campbell
Title Product Manager


GNA is developing a portable, low-cost, user-friendly platform that will bring fast and sensitive molecular tests to the patients that need them, at the right place, at the right time.   Our goal is to accelerate & simplify molecular diagnostic testing at the POC, offering sample & multiplexing flexibility to support implementation in a range of POC environments. Our planned launch test menu includes infectious disease assays for Multi-drug resistant tuberculosis (MDR-TB), Methicillin-resistant Staphylococcus aureus (MRSA) and multi-drug resistant Gram-negative bacteria (MDRGN).

Company News